MRS 1754

CAS No. 264622-58-4

MRS 1754( —— )

Catalog No. M26764 CAS No. 264622-58-4

MRS 1754 is a selective antagonist radioligand for the A2B adenosine receptor. It has a very low affinity for A1 and A3 receptors of both humans and rats.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 30 In Stock
5MG 50 In Stock
10MG 84 In Stock
25MG 183 In Stock
50MG 286 In Stock
100MG 417 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MRS 1754
  • Note
    Research use only, not for human use.
  • Brief Description
    MRS 1754 is a selective antagonist radioligand for the A2B adenosine receptor. It has a very low affinity for A1 and A3 receptors of both humans and rats.
  • Description
    MRS 1754 is a selective antagonist radioligand for the A2B adenosine receptor. It has a very low affinity for A1 and A3 receptors of both humans and rats.(In Vitro):The Ki value for displacement of [3H]MRS 1754 binding to human A2B receptors expressed in HEK-293 cell membranes is 1.45±0.21 nM. The most effective displacer of [3H]MRS 1754 binding is MRS 1754. .
  • In Vitro
    The most potent displacer of [3H]MRS 1754 binding is MRS 1754. The Ki value for displacement of [3H]MRS 1754 binding to human A2B receptors expressed in HEK-293 cell membranes is 1.45±0.21 nM.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Adenosine Receptor
  • Recptor
    JAK1| JAK3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    264622-58-4
  • Formula Weight
    486.532
  • Molecular Formula
    C26H26N6O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 15 mg/mL (30.83 mM)
  • SMILES
    CCCn1c2nc([nH]c2c(=O)n(CCC)c1=O)-c1ccc(OCC(=O)Nc2ccc(cc2)C#N)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Li Hui, et al.Preparation of phenylaminopyrimidinylaminooxobenzooxazole derivatives for use as JAK kinase inhibitors. WO2012015972A1
molnova catalog
related products
  • Xanthine amine conge...

    XAC is an Adenosine receptor antagonist.

  • ST-4206

    A metabolite of ST1535, which is potent, selective A2A adenosine receptor antagonist with Ki of 6.6 nM.

  • AB928

    AB928 is a dual antagonist of the A2aR and A2bR adenosine receptors leads to greater immune activation and reduced tumor growth when combined with chemotherapy.